Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
LALPATHLAB.NSthis companyDr. Lal PathLabs Limited	₹2,016.50	43.39×	8.73×	7.93×	25.61×	4.3%	42.0%	22.5%	18.3%	20.1%	16.9%	2.4%	0.08×	-0.05×	27.22×	3.48×	1.0%	4	—	2	C+
ASPIRA.BOAspira Pathlab & Diagnostics Limited	₹126.95	1,117×	4.68×	2.29×	40.57×	-50.8%	35.3%	-0.3%	0.2%	0.4%	-0.5%	1.9%	0.27×	1.41×	-0.19×	1.43×	0.0%	2	—	1	C-
DLCL.BODr. Lalchandani Labs Ltd.	₹6.47	93.8×	0.43×	1.46×	5.92×	658.4%	59.7%	-11.9%	1.5%	0.4%	-2.0%	-17.9%	0.15×	-3.04×	-28.75×	3.79×	0.0%	3	1.33	2	B-
METROPOLIS.NSMetropolis Healthcare Limited	₹582.35	47.23×	5.93×	5.45×	21.92×	69.1%	47.8%	16.2%	11.5%	12.6%	10.4%	3.3%	0.15×	0.42×	10.88×	1.4×	0.2%	4	—	2	C+
NIDAN.NSNidan Laboratories & Healthcare Ltd.	₹13.35	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
SURAKSHA.NSSuraksha Diagnostic Ltd.	₹350.40	36.89×	4.85×	3.82×	13.47×	-74.2%	57.7%	17.5%	10.4%	13.1%	9.5%	1.4%	0.53×	1.08×	4.33×	1.05×	0.0%	5	—	2	C
Peer median	—	70.51×	4.77×	3.06×	17.7×	9.2%	52.8%	8.0%	5.9%	6.5%	4.5%	1.6%	0.21×	0.75×	2.07×	1.42×	0.0%	4	1.33	2	—